Dermatology Drugs Global Market Report 2022

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Name: Dermatology Drugs Global Market Report 2022
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Dermatology Drugs Global Market Report 2022

Starting Price : $5000.00 $4000.00 | Pages : 300 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The dermatology drugs market consists of sales of dermatology drugs by entities (organizations, sole traders and partnerships) that produce dermatology drugs to treat skin diseases. This industry includes establishments that produce drugs to treat diseases such as rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne drugs, microbial infections and other skin disorders.

The main types of dermatology drugs are acne drugs, dermatitis, psoriasis, and other drugs for dermatology diseases. Psoriasis is a skin condition that causes red, itchy scaly patches on the knees, elbows, trunk, and scalp. Hypolipidemic drugs are a diverse class of medications used to treat high levels of fats (lipids) in the blood, such as cholesterol (hyperlipidemia). The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

The global dermatology drugs market size is expected to grow from $49.55 billion in 2021 to $54.54 billion in 2022 at a compound annual growth rate (CAGR) of 10.1%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The dermatology drugs market is expected to reach $117.82 billion in 2026 at a CAGR of 21.2%.

The dermatology drugs market was mainly driven by rapid growth in emerging markets in the historic period. Emerging markets growth was aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP growth rate was 2.3% in 2020. Additionally, according to the World Economic Outlook Reports by the IMF, the global growth is 6% in 2021 and expected to be 4.4% in 2022. Thus, strong economic growth boosted the demand for dermatology drugs and this drove the market during the historic period.

High costs associated with drugs is a major issue faced by citizens of many countries. Pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, the pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of dermatology drugs manufacturers.

Drug manufacturing companies are using genome testing (genetic diagnosis) to reduce the time and costs spent in clinical trials. A clinical trial is a complex process and it often takes months for a drug to be available in the market. This deprives patients of cost-effective treatment. Researchers in the Rockefeller University used genomic testing and data analytics to predict the response of psoriasis patients for a given treatment. Genomic testing algorithms collect gene-expression data from skin biopsies and detect activity in 50,000 different genes. This technique can predict the response of a patient with an accuracy of 95% and within 12 weeks, thus saving significant time for clinical trials and the launch of new drugs.

Major companies in the dermatology drugs market include Amgen, Reckitt Benckiser Group plc, AbbVie, Galderma S.A., LEO Pharma A/S, Bayer AG, GlaxosmithKline, Eli Lilly And Company, Novartis AG and Perrigo Company Plc.

North America was the largest region in the dermatology drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the dermatology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dermatology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global dermatology drugs market is segmented -

1) By Type: Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Book your 30 minutes free consultation with our research experts

1. Executive Summary

2. Report Structure

3. Dermatology Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Dermatology Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Dermatology Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Dermatology Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Dermatology Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Dermatology Drugs

9. Dermatology Drugs Market Size And Growth

9.1. Market Size

9.2. Historic Market Growth, Value ($ Billion)

9.2.1. Drivers Of The Market

9.2.2. Restraints On The Market

9.3. Forecast Market Growth, Value ($ Billion)

9.3.1. Drivers Of The Market

9.3.2. Restraints On The Market

10. Dermatology Drugs Market Regional Analysis

10.1. Global Dermatology Drugs Market, 2021, By Region, Value ($ Billion)

10.2. Global Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

10.3. Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

11. Dermatology Drugs Market Segmentation

11.1. Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Acne Drugs

Dermatitis

Psoriasis

Other Drugs for Dermatology Diseases

11.2. Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

11.3. Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Oral

Parenteral

Others

11.4. Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Branded Drugs

Generic Drugs

11.5. Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

12. Dermatology Drugs Market Metrics

12.1. Dermatology Drugs Market Size, Percentage Of GDP, 2016-2026, Global

12.2. Per Capita Average Dermatology Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Dermatology Drugs Market

13.1. Asia-Pacific Dermatology Drugs Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. Asia-Pacific, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

13.3. Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

13.4. Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

13.5. Asia-Pacific, Dermatology Drugs Market Metrics

13.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Asia-Pacific Countries

13.6. Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7. Asia-Pacific Dermatology Drugs Market: Country Analysis

13.7.1. China Dermatology Drugs Market

13.7.1.1. China Dermatology Drugs Market Overview

13.7.1.2. China Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.1.3. China Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2. Australia Dermatology Drugs Market

13.7.2.1. Australia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2.2. Australia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.3. Hong Kong Dermatology Drugs Market

13.7.3.1. Hong Kong Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4. India Dermatology Drugs Market

13.7.4.1. India Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4.2. India Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5. Indonesia Dermatology Drugs Market

13.7.5.1. Indonesia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5.2. Indonesia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6. Japan Dermatology Drugs Market

13.7.6.1. Japan Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6.2. Japan Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.7. Malaysia Dermatology Drugs Market

13.7.7.1. Malaysia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.8. New Zealand Dermatology Drugs Market

13.7.8.1. New Zealand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.9. Philippines Dermatology Drugs Market

13.7.9.1. Philippines Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.10. Singapore Dermatology Drugs Market

13.7.10.1. Singapore Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11. South Korea Dermatology Drugs Market

13.7.11.1. South Korea Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11.2. South Korea Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.12. Thailand Dermatology Drugs Market

13.7.12.1. Thailand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.13. Vietnam Dermatology Drugs Market

13.7.13.1. Vietnam Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Dermatology Drugs Market

14.1. Western Europe Dermatology Drugs Market Overview

14.2. Western Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

14.3. Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

14.4. Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

14.5. Western Europe, Dermatology Drugs Market Metrics

14.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Western Europe Countries

14.6. Western Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7. Western Europe Dermatology Drugs Market: Country Analysis

14.7.1. Austria Dermatology Drugs Market

14.7.1.1. Austria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.2. Belgium Dermatology Drugs Market

14.7.2.1. Belgium Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.3. Denmark Dermatology Drugs Market

14.7.3.1. Denmark Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.4. Finland Dermatology Drugs Market

14.7.4.1. Finland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5. France Dermatology Drugs Market

14.7.5.1. France Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5.2. France Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6. Germany Dermatology Drugs Market

14.7.6.1. Germany Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6.2. Germany Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.7. Ireland Dermatology Drugs Market

14.7.7.1. Ireland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.8. Italy Dermatology Drugs Market

14.7.8.1. Italy Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.9. Netherlands Dermatology Drugs Market

14.7.9.1. Netherlands Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.10. Norway Dermatology Drugs Market

14.7.10.1. Norway Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.11. Portugal Dermatology Drugs Market

14.7.11.1. Portugal Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.12. Spain Dermatology Drugs Market

14.7.12.1. Spain Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.13. Sweden Dermatology Drugs Market

14.7.13.1. Sweden Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.14. Switzerland Dermatology Drugs Market

14.7.14.1. Switzerland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15. UK Dermatology Drugs Market

14.7.15.1. UK Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15.2. UK Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Dermatology Drugs Market

15.1. Eastern Europe Dermatology Drugs Market Overview

15.2. Eastern Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

15.3. Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

15.4. Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

15.5. Eastern Europe, Dermatology Drugs Market Metrics

15.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Eastern Europe Countries

15.6. Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7. Eastern Europe Dermatology Drugs Market: Country Analysis

15.7.1. Czech Republic Dermatology Drugs Market,

15.7.1.1. Czech Republic Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.2. Poland Dermatology Drugs Market

15.7.2.1. Poland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.3. Romania Dermatology Drugs Market

15.7.3.1. Romania Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4. Russia Dermatology Drugs Market

15.7.4.1. Russia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4.2. Russia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Dermatology Drugs Market

16.1. North America Dermatology Drugs Market Overview

16.2. North America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

16.3. North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

16.4. North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

16.5. North America, Dermatology Drugs Market Metrics

16.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, North America Countries

16.6. North America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7. North America Dermatology Drugs Market: Country Analysis

16.7.1. Canada Dermatology Drugs Market

16.7.1.1. Canada Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.2. Mexico Dermatology Drugs Market

16.7.2.1. Mexico Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3. USA Dermatology Drugs Market

16.7.3.1. USA Dermatology Drugs Market Overview

16.7.3.2. USA Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3.3. USA Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Dermatology Drugs Market

17.1. South America Dermatology Drugs Market Overview

17.2. South America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

17.3. South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

17.4. South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

17.5. South America, Dermatology Drugs Market Metrics

17.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, South America Countries

17.6. South America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7. South America Dermatology Drugs Market: Country Analysis

17.7.1. Argentina Dermatology Drugs Market

17.7.1.1. Argentina Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2. Brazil Dermatology Drugs Market

17.7.1.1. Brazil Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2.2. Brazil Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.3. Chile Dermatology Drugs Market

17.7.3.1. Chile Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.4. Colombia Dermatology Drugs Market

17.7.4.1. Colombia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.5. Peru Dermatology Drugs Market

17.7.5.1. Peru Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.6. Venezuela Dermatology Drugs Market

17.7.6.1. Venezuela Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Dermatology Drugs Market

18.1. Middle East Dermatology Drugs Market Overview

18.2. Middle East, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

18.3. Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

18.4. Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

18.5. Middle East, Dermatology Drugs Market Metrics

18.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Middle East Countries

18.6. Middle East Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7. Middle East Dermatology Drugs Market: Country Analysis

18.7.1. Saudi Arabia Dermatology Drugs Market

18.7.1.1. Saudi Arabia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.2. Israel Dermatology Drugs Market

18.7.2.1. Israel Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.3. Turkey Dermatology Drugs Market

18.7.3.1. Turkey Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.4. UAE Dermatology Drugs Market

18.7.4.1. UAE Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Dermatology Drugs Market

19.1. Africa Dermatology Drugs Market Overview

19.2. Africa, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

19.3. Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

19.4. Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

19.5. Africa, Dermatology Drugs Market Metrics

19.5.1. Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Africa Countries

19.6. Africa Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7. Africa Dermatology Drugs Market: Country Analysis

19.7.1. Egypt Dermatology Drugs Market

19.7.1.1. Egypt Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.2. Nigeria Dermatology Drugs Market

19.7.2.1. Nigeria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.3. South Africa Dermatology Drugs Market

19.7.3.1. South Africa Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Dermatology Drugs Market Competitive Landscape

20.1. Competitive Market Overview

20.2. Market Shares

20.3. Company Profiles

20.3.1. Amgen

20.3.1.1. Company Overview

20.3.1.2. Products And Services

20.3.1.3. Strategy

20.3.1.4. Financial Performance

20.3.2. Reckitt Benckiser Group plc

20.3.2.1. Company Overview

20.3.2.2. Products And Services

20.3.2.3. Strategy

20.3.2.4. Financial Performance

20.3.3. AbbVie

20.3.3.1. Company Overview

20.3.3.2. Products And Services

20.3.3.3. Strategy

20.3.3.4. Financial Performance

20.3.4. Galderma S.A.

20.3.4.1. Company Overview

20.3.4.2. Products And Services

20.3.4.3. Strategy

20.3.4.4. Financial Performance

20.3.5. LEO Pharma A/S

20.3.5.1. Company Overview

20.3.5.2. Products And Services

20.3.5.3. Strategy

20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Dermatology Drugs Market

22. Market Background: Pharmaceutical Drugs Market

22.1. Pharmaceutical Drugs Market Characteristics

22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

23.1. Global Dermatology Drugs Market In 2026- Growth Countries

23.2. Global Dermatology Drugs Market In 2026- Growth Segments

23.3. Global Dermatology Drugs Market In 2026- Growth Strategies

24. Appendix

24.1. NAICS Definitions Of Industry Covered In This Report

24.2. Abbreviations

24.3. Currencies

24.4. Research Inquiries

24.5. The Business Research Company

25. Copyright And Disclaimer

List Of Tables

Table 1: Historic Market Growth, Value ($ Billion)

Table 2: Forecast Market Growth, Value ($ Billion)

Table 3: Global Dermatology Drugs Market, 2021, By Region, Value ($ Billion)

Table 4: Global Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 5: Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 7: Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 8: Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 9: Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 10: Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 11: Dermatology Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Table 12: Per Capita Average Dermatology Drugs Market Expenditure, 2016-2026, Global

Table 13: Asia-Pacific, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 14: Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 15: Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 16: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Table 17: Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 18: China Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 19: China Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 20: Australia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 21: Australia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 22: Hong Kong Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 23: India Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 24: India Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 25: Indonesia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 26: Indonesia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 27: Japan Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 28: Japan Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 29: Malaysia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 30: New Zealand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 31: Philippines Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 32: Singapore Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 33: South Korea Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 34: Thailand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 35: Vietnam Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 36: Western Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 37: Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 38: Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 39: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Western Europe Countries

Table 40: Western Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 41: Austria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 42: Belgium Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 43: Denmark Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 44: Finland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 45: France Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 46: France Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 47: Germany Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 48: Germany Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 49: Ireland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 50: Italy Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 51: Netherlands Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 52: Norway Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 53: Portugal Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 54: Spain Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 55: Sweden Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 56: Switzerland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 57: UK Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 58: UK Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 59: Eastern Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 60: Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 61: Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 62: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Eastern Europe Countries

Table 63: Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 64: Czech Republic Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 65: Poland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 66: Romania Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 67: Russia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 68: Russia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 69: North America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 70: North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 71: North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 72: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, North America Countries

Table 73: North America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 74: Canada Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 75: Mexico Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 76: USA Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 77: USA Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 78: South America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 79: South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 80: South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 81: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, South America Countries

Table 82: South America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 83: Argentina Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 84: Brazil Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 85: Brazil Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 86: Chile Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 87: Colombia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 88: Peru Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 89: Venezuela Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 90: Middle East, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 91: Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 92: Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 93: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Middle East Countries

Table 94: Middle East Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 95: Saudi Arabia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 96: Israel Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 97: Turkey Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 98: UAE Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 99: Africa, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Table 100: Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 101: Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 102: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Africa Countries

Table 103: Africa Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 104: Egypt Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 105: Nigeria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 106: South Africa Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 107: Amgen Financial Performance

Table 108: Reckitt Benckiser Group plc Financial Performance

Table 109: AbbVie Financial Performance

Table 110: Galderma S.A. Financial Performance

Table 111: LEO Pharma A/S Financial Performance

Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Table 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Table 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Table 116: Global Dermatology Drugs Market In 2026- Growth Countries

Table 117: Global Dermatology Drugs Market In 2026- Growth Segments

Table 118: Global Dermatology Drugs Market In 2026- Growth Strategies

List Of Figures

Figure 1: Historic Market Growth, Value ($ Billion)

Figure 2: Forecast Market Growth, Value ($ Billion)

Figure 3: Global Dermatology Drugs Market, 2021, By Region, Value ($ Billion)

Figure 4: Global Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 5: Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 7: Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 8: Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 9: Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 10: Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 11: Dermatology Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Figure 12: Per Capita Average Dermatology Drugs Market Expenditure, 2016-2026, Global

Figure 13: Asia-Pacific, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 14: Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 15: Asia-Pacific, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 16: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Figure 17: Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 18: China Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 19: China Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 20: Australia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 21: Australia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 22: Hong Kong Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 23: India Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 24: India Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 25: Indonesia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 26: Indonesia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 27: Japan Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 28: Japan Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 29: Malaysia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 30: New Zealand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 31: Philippines Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 32: Singapore Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 33: South Korea Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 34: Thailand Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 35: Vietnam Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 36: Western Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 37: Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 38: Western Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 39: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Western Europe Countries

Figure 40: Western Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 41: Austria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 42: Belgium Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 43: Denmark Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 44: Finland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 45: France Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 46: France Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 47: Germany Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 48: Germany Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 49: Ireland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 50: Italy Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 51: Netherlands Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 52: Norway Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 53: Portugal Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 54: Spain Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 55: Sweden Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 56: Switzerland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 57: UK Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 58: UK Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 59: Eastern Europe, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 60: Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 61: Eastern Europe, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 62: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Eastern Europe Countries

Figure 63: Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 64: Czech Republic Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 65: Poland Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 66: Romania Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 67: Russia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 68: Russia Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 69: North America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 70: North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 71: North America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 72: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, North America Countries

Figure 73: North America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 74: Canada Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 75: Mexico Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 76: USA Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 77: USA Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 78: South America, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 79: South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 80: South America, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 81: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, South America Countries

Figure 82: South America Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 83: Argentina Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 84: Brazil Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 85: Brazil Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 86: Chile Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 87: Colombia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 88: Peru Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 89: Venezuela Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 90: Middle East, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 91: Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 92: Middle East, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 93: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Middle East Countries

Figure 94: Middle East Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 95: Saudi Arabia Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 96: Israel Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 97: Turkey Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 98: UAE Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 99: Africa, Dermatology Drugs Market, 2021, By Country, Value ($ Billion)

Figure 100: Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 101: Africa, Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 102: Per Capita Average Dermatology Drugs Expenditure, 2016-2026, Africa Countries

Figure 103: Africa Dermatology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 104: Egypt Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 105: Nigeria Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 106: South Africa Dermatology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 107: Amgen Financial Performance

Figure 108: Reckitt Benckiser Group plc Financial Performance

Figure 109: AbbVie Financial Performance

Figure 110: Galderma S.A. Financial Performance

Figure 111: LEO Pharma A/S Financial Performance

Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Figure 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Figure 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Figure 116: Global Dermatology Drugs Market In 2026- Growth Countries

Figure 117: Global Dermatology Drugs Market In 2026- Growth Segments

Figure 118: Global Dermatology Drugs Market In 2026- Growth Strategies

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Dermatitis Global Market Report 2024 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antifungals Global Market Report 2024 – By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By Route of Administration (Oral, Parenteral, Topical), By End users (Hospitals & Clinics, Dermatology clinics, Other Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilar Therapeutic Peptides Global Market Report 2024 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dermatology Medical Lasers Global Market Report 2024 – By Device (Surgical Lasers, Vascular Lasers), By Application (Cancer, Hair Removal, Tattoo Removal, Resurfacing, Other Applications), By End-users (Hospitals, Skin Care Clinics, Cosmetic Surgical Centres) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Psoriasis Global Market Report 2024 – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis), By Route Of Administration (Oral, Tropical, Injectable ), By Distribution Channel (Hospitals, Retail Pharmacies, E-Commerce ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acne Drugs Market 2021 - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics), By Therapeutic Class (Benzoyl Peroxide, Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Generic Pharmaceuticals Global Market Report 2024 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the dermatology drugs market?

The dermatology drugs market consists of sales of dermatology drugs by entities that produce dermatology drugs to treat skin diseases. This industry includes establishments that produce drugs to treat diseases such as rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections and other skin disorders request a sample here

How will the dermatology drugs market drivers and restraints affect dermatology drugs market dynamics? What forces will shape the dermatology drugs industry going forward?

The dermatology drugs market growth is aided by rise in rapid growth in emerging markets. However, some dermatology drugs market restraints include high costs associated with drugs. request a sample here

What is the forecast market size of the dermatology drugs market?

The dermatology drugs market forecast is expected to reach $62.83 billion in 2025 at a compound annual growth rate of 12%. request a sample here

How is the dermatology drugs market segmented?

The global dermatology drugs market is segmented -
1) By Type: Acne, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the dermatology drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global dermatology drugs market?

Top competitors in the dermatology drugs market are Johnson & Johnson, Allergan Plc, Galderma S.A, Novartis AG, GlaxoSmithKline Plc. request a sample here.

What are the key trends in the global dermatology drugs market?

Major trends influencing the dermatology drugs market include use of genome testing (genetic diagnosis) to reduce the time and costs spent in clinical trials. request a sample here.

What are the major opportunities in the dermatology drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global dermatology drugs market, request a sample here.

How does the dermatology drugs market relate to the overall economy and other similar markets?

request a sample here.